| Literature DB >> 9848576 |
T H Corbett1, P LoRusso, L Demchick, C Simpson, S Pugh, K White, J Kushner, L Polin, J Meyer, J Czarnecki, L Heilbrun, J P Horwitz, J L Gross, C H Behrens, B A Harrison, R J McRipley, G Trainor.
Abstract
A series of quinoxaline analogs of the herbicide Assure was found to have selective cytotoxicity for solid tumors of mice in a disk-diffusion-soft-agar-colony-formation-assay compared to L1210 leukemia. Four agents without selective cytotoxicity and 14 agents with selective cytotoxicity were evaluated in vivo for activity against a solid tumor. The four agents without selective cytotoxicity in the disk-assay were inactive in vivo (T/C > 42%). Thirteen of the fourteen agents with selectivity in the disk-assay were active in vivo (T/C < 42%). Five of the agents had curative activity. These five agents had a halogen (F, Cl, Br) in the 7-position (whereas Assure had a CI in the 6 position). All agents with curative activity were either a carboxylic acid, or a derivative thereof, whereas Assure is the ethyl ester of the carboxylic acid. All other structural features were identical between Assure and the curative agents. Assure had no selective cytotoxicity for solid tumors in the disk-assay, and was devoid of antitumor activity. The analog XK469 is in clinical development.Entities:
Mesh：
Substances：
Year: 1998 PMID： 9848576 DOI： 10.1023/a:1006174622061
Source DB: PubMed Journal: Invest New Drugs ISSN： 0167-6997 Impact factor: 3.850